Evidence map›Paper›PMID 27957009›Full record

ArticleGastroenterology research2011

Role of Alendronate in Managing Osteoporosis in Celiac Disease - Illustrative Case Report.

David Widjaja, Kalyan C Kanneganti, Madanmohan Patel, Sridhar S Chilimuri

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Gastroenterology research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Celiac disease: A missed cause of metabolic bone disease.Indian journal of endocrinology and metabolism · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David WidjajaDepartment of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
Kalyan C KannegantiDepartment of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
Madanmohan PatelDepartment of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
Sridhar S ChilimuriDepartment of Medicine, Bronx Lebanon Hospital Center, 1650 Selwyn Ave, 10th Floor, Bronx, NY 10457, USA.
Bronx-Lebanon Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Management of bone density loss, as the result of calcium malabsorption in celiac disease, is critical in preventing premature bone fracture. As many of these patients need follow-up with primary care providers, internists are expected to be aware of screening and prompt management of osteopenia or osteoporosis in celiac disease. We present a case of a 32-year-old man with celiac disease who was diagnosed with osteoporosis. He was treated with calcium, vitamin D and alendronate which improved bone mineral density. This case illustrates the importance of using bisphosphonate in treating osteoporosis in celiac disease.

Indexed as

AlendronateCeliac diseaseOsteoporosis

Identifiers

PMID27957009
PMCPMC5139797
OpenAlexW2127466964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.